Why is Jenburkt Pharma falling/rising?

As of 23-Sep, Jenburkt Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 1,057.00, reflecting a decrease of 29.8 points or 2.74%. The stock has been underperforming, having lost 5.79% over the last three days and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the delivery volume has decreased significantly, falling by 24.94% compared to the 5-day average, indicating reduced investor participation. The stock's performance over the past week shows a decline of 4.86%, while its year-to-date return is down 12.98%, contrasting with the Sensex, which has gained 5.07% over the same period.
In the broader market context, Jenburkt Pharmaceuticals' recent performance has been notably weaker than the benchmark, as it has underperformed the Sensex by 2.39% today. While the Sensex has shown a slight increase of 0.98% over the past month, Jenburkt's stock has declined by 6.46% in the same timeframe. This disparity highlights the challenges the company is facing in attracting investor interest and maintaining its stock value amidst a generally positive market environment.